Description

The role of imaging as an outcome measure in cystic fibrosis research and clinical care is increasing through introduction of new techniques and maturation of existing methods. This session showcases some recent work in developing these tools and comparing them with alternative biomarkers of lung disease such as lung clearance index.

• Describe the potential role of hyperpolarized gas MRI in characterizing CF lung disease.
• Compare the performance of MRI with CT in assessing CF lung disease.
• Summarize the effectiveness of MRI compared with lung clearance index in assessing mild CF lung disease.

Chair(s):

• Scott Nagle, M.D., Ph.D., University of Wisconsin
• Jason Woods, Ph.D., Cincinnati Children s Hospital Medical Center

Speaker(s):

• Hartmut Grasemann, MD
• Laura Walkup, Ph.D.
• Wieying Kuo
• Robert Thomen, M.S.